Pharmaceutical Regulatory Affairs in Africa: 2-Day Online Training Course (July 23-24, 2024) with CPD Certification
30 mai 2024 04h18 HE
|
Research and Markets
Dublin, May 30, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Regulatory Affairs in Africa Training Course" conference has been added to ResearchAndMarkets.com's offering. The value of the African...
Power of Recursion OS on Display at Genome Scale in Nature Genetics Paper Detailing Potential Limitation of CRISPR Gene Editing Tool
29 mai 2024 15h27 HE
|
Recursion Pharmaceuticals
SALT LAKE CITY, May 29, 2024 (GLOBE NEWSWIRE) -- Recursion (Nasdaq: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today published in Nature...
Best Peptides Company of 2024 Announced As Limitless Biotech
29 mai 2024 09h00 HE
|
Limitless Biotech
Gulf Breeze, FL, May 29, 2024 (GLOBE NEWSWIRE) -- Limitless Biotech, a leading provider of high-quality peptides, proudly announces its ascension as the best peptide company in the industry. Through...
PSMF Online Training Course: A Technical Training Program on Creating and Maintaining Pharmacovigilance System Master File (PSMF)
28 mai 2024 04h43 HE
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "PSMF Online Training - A Technical Training Program on Creating and Maintaining Pharmacovigilance System Master File (PSMF)" training has been added to ...
PSUR/PBRER Online Training Program: Professional Training on Developing, Managing and Reporting of PSURs/PBRERs in Pharmacovigilance
28 mai 2024 04h41 HE
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "PSUR/PBRER Online Training - Professional Training Program on Developing, Managing and Reporting of PSURs/PBRERs in Pharmacovigilance" training has been...
Pharmaceutical Document Management 3 Day Online Training Course: A Global Regulatory Approach (August 12-14, 2024)
28 mai 2024 03h44 HE
|
Research and Markets
Dublin, May 28, 2024 (GLOBE NEWSWIRE) -- The "Pharmaceutical Document Management Training Course - A Global Regulatory Approach" training has been added to ResearchAndMarkets.com's offering. In...
Ivy Brain Tumor Center announces Phase 0/2 clinical readout of niraparib indicating significant improvement in overall survival of newly diagnosed glioblastoma patients
23 mai 2024 17h09 HE
|
Ivy Brain Tumor Center
Phoenix, AZ, May 23, 2024 (GLOBE NEWSWIRE) -- Results will be presented at American Society of Clinical Oncology (ASCO) Annual MeetingMedian overall survival was 20.3 months, nearly doubling the...
Syntekabio to Showcase Advanced AI Drug Discovery Technologies at BIO International Convention 2024
23 mai 2024 10h00 HE
|
Syntekabio USA Inc.
NEW YORK, May 23, 2024 (GLOBE NEWSWIRE) -- Syntekabio (226330.KQ), a global artificial intelligence (AI) drug discovery pioneer, today announced its participation at the BIO International Convention...
Pattern Announces Commencement of Synergy and Efficacy Testing for Promising High-grade Serous Ovarian Cancer Program Combinations
22 mai 2024 08h30 HE
|
PATTERN COMPUTER, INC.
REDMOND, Wash., May 22, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) proudly announces the initiation of synergy and efficacy testing for two promising drug...
Pattern to Present at 2024 BIO International Convention
21 mai 2024 08h30 HE
|
PATTERN COMPUTER, INC.
REDMOND, Wash., May 21, 2024 (GLOBE NEWSWIRE) -- Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that Mark R. Anderson, Chairman and CEO, will present at the upcoming 2024 BIO...